PR Newswire Clinical TrialsOriginal article
Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™
eSTRAND RNA QC™Positive
AI Analysis
Summary
Eclipsebio announced the expansion of its RNA characterization capabilities with eSTRAND RNA QC™, a nanopore-based direct RNA sequencing assay for multi-attribute RNA analysis without reverse transcription requirements.
Importance:2/10
Sentiment:
0.30
product launchtechnology platformRNA sequencingnanoporequality control
Read the original article
Published by PR Newswire Clinical Trials on September 1, 2026 1:00 PM
